Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo

By Wei Lan   Kawano Hiroo   Fu Xiaoying   Cui Dan   Ito Sadahiro   Yamamura Ken-ichi   Ishihara Tokuhiro   Tokuda Takahiko   Higuchi Keiichi   Maeda Shuichiro  

Amyloid: The Journal of Protein Folding Disorders, Vol. 11, Iss. 2, 2004-06 ,pp. : 113-120

Informa Healthcare

Access to resources Recommend Favorite

Amyloidogenesis is neither accelerated nor enhanced by injections of preformed fibrils in mice transgenic for wild-type human transthyretin: the question of infectivity

By Tagoe Clement   French David   Gallo Gloria   Buxbaum Joel  

Amyloid: The Journal of Protein Folding Disorders, Vol. 11, Iss. 1, 2004-03 ,pp. : 21-26

Informa Healthcare

Access to resources Recommend Favorite

Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience

By Suhr Ole B.   Ericzon Bo-Göran  

Amyloid: The Journal of Protein Folding Disorders, Vol. 19, Iss. 1, 2012-06 ,pp. : 78-80

Informa Healthcare

Access to resources Recommend Favorite

Intranasal Phosphoramidon Increases Beta-Amyloid Levels in Wild-Type and NEP/NEP2-Deficient Mice

By Hanson Leah   Hafez Daniel   Svitak Aleta   Burns Rachel   Li Xuan   Frey William   Marr Robert  

Journal of Molecular Neuroscience, Vol. 43, Iss. 3, 2011-03 ,pp. : 424-427

Humana Press, Inc

Access to resources Recommend Favorite

In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity

By Kumar-Singh S.   Julliams A.   Nuydens R.   Ceuterick C.   Labeur C.   Serneels S.   Vennekens K.   van Osta P.   Geerts H.   de Strooper B.   van Broeckhoven C.  

Neurobiology of Disease, Vol. 11, Iss. 2, 2002-11 ,pp. : 330-340

Academic Press

Access to resources Recommend Favorite